Zicfi SL 1000mg/500mg Injection
Marketer
Biotic Healthcare
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Zicfi SL 1000mg/500mg Injection
Combiflox SL Injection (1000mg/500mg) is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thereby curbing infection spread. Administration must be strictly under medical guidance. Complete the prescribed dosage regimen; premature cessation may compromise efficacy. Report any missed appointments immediately. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or persistent side effects necessitate immediate medical attention. Seek emergency care for allergic reactions (e.g., rash, itching, edema, dyspnea). Inform your physician about all concurrent medications, including over-the-counter drugs. Pregnant or lactating individuals require physician consultation prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occur. Adequate rest, balanced nutrition, and hydration are crucial for optimal recovery. Your doctor might order blood tests and other assessments to monitor treatment response.
Uses of Zicfi SL 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Zicfi SL 1000mg/500mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Zicfi SL 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Zicfi SL 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Zicfi SL 1000mg/500mg Injection works:
Ceftriaxone and Sulbactam, combined as Zicfi SL 1000mg/500mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a third-generation cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to reproduce. Sulbactam's role as a beta-lactamase inhibitor counteracts bacterial resistance mechanisms, thus maximizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
The concomitant use of alcohol and Zicfi SL 1000mg/500mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Zicfi SL (1000mg/500mg) is typically deemed safe for use in pregnant individuals. Preclinical trials using animal models revealed minimal or no harm to the fetus; nonetheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Zicfi SL 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended throughout the course of maternal treatment and until the medication is fully cleared from the patient's system.
DrivingUNSAFE
Administering Zicfi SL 1000mg/500mg Injection might cause drowsiness, blurred vision, or dizziness. Refrain from driving if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Zicfi SL 1000mg/500mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Administering Zicfi SL 1000mg/500mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Medical advice is recommended. Dosage alteration for Zicfi SL 1000mg/500mg Injection is unnecessary for those with mild or moderate liver dysfunction.
What if you forget to take Zicfi SL 1000mg/500mg Injection :
Omitting a scheduled dose of Zicfi SL 1000mg/500mg Injection necessitates contacting your physician.
Facts to Know About Zicfi SL 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently